Dr Google will see you now! Women diagnosed with ovarian cancer look up tell-tale symptoms of deadly disease a YEAR before being diagnosed
Women battling the disease looked up symptoms including weight loss , bladder problems and bloating up to 360 days before being referred to a specialist. (Source: the Mail online | Health)
Source: the Mail online | Health - March 11, 2024 Category: Consumer Health News Source Type: news

Drug Combo Marks Advance Against Bladder Cancer
MONDAY, March 11, 2024 -- A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 11, 2024 Category: General Medicine Source Type: news

First-Line Nivolumab Plus Chemo Approved for Bladder Cancer
(MedPage Today) -- The FDA approved the PD-1 immune checkpoint inhibitor nivolumab (Opdivo) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic urothelial carcinoma, the agency announced... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news

Dr Amir shares 11 warning signs of the 'least talked about' cancer
The TV doctor warns that symptoms of bladder cancer can be dismissed as something else, and urges everyone who experiences one tell-tale sign to get checked. (Source: Daily Express - Health)
Source: Daily Express - Health - February 14, 2024 Category: Consumer Health News Source Type: news

Defense Secretary Austin transfers powers to deputy while back in hospital
Defense Secretary Lloyd Austin was hospitalized again Sunday to address a bladder issue as he continues to recover from prostate cancer and has transferred authorities to his deputy, the Pentagon said. Austin was diagnosed with prostate cancer in December and continues to deal with complications…#defense #lloydaustin #pentagon #pentagonpress #patryder #defensekathleenhicks #walterreed #johnmaddox #gregorychesnut #austin (Source: Reuters: Health)
Source: Reuters: Health - February 12, 2024 Category: Consumer Health News Source Type: news

Defense Secretary Returns to Hospital With Bladder Issues
MONDAY, Feb. 12, 2024 (Healthday News) -- Defense Secretary Lloyd Austin III, who spent time in intensive care last month for complications related to prostate cancer surgery performed in December, has returned to the hospital with bladder issues,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 12, 2024 Category: General Medicine Source Type: news

Lloyd Austin hospitalized with " emergent bladder issue, " Pentagon says
Defense Secretary Lloyd Austin was hospitalized again on Sunday, this time "for symptoms suggesting an emergent bladder issue," the Pentagon announced. The big picture: Less than a month after he was released from the hospital following complications from a treatment for prostate cancer, Pentagon…#defense #lloydaustin #pentagon #patryder #ryder #jointchiefsofstaff #congressional (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2024 Category: Consumer Health News Source Type: news

Top Causes of Early Noncancer Deaths in Advanced GU Cancers Top Causes of Early Noncancer Deaths in Advanced GU Cancers
Sepsis was the leading reason for early noncancer deaths in patients with metastatic bladder, kidney, or prostate cancer, a recent analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

'I'm a doctor - here are four symptoms of bladder cancer to get checked out'
If you notice any of these worrying symptoms you should speak to your GP. (Source: Daily Express - Health)
Source: Daily Express - Health - February 1, 2024 Category: Consumer Health News Source Type: news

First-Line Combo for Cisplatin-Ineligible Bladder Cancer Just Misses Positive Result
(MedPage Today) -- SAN FRANCISCO -- Almost half of patients with untreated cisplatin-ineligible advanced urothelial carcinoma responded to the combination of pembrolizumab (Keytruda) and cabozantinib (Cabometyx), but that result fell short of... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 29, 2024 Category: Hematology Source Type: news

CT radiomics predict lymph node metastasis in bladder cancer patients
A deep-learning model that combines CT radiomics and clinical information shows promise for predicting lymph node metastasis in bladder cancer patients, researchers have reported. The study results could offer clinicians a better way to assess the prognosis of individuals with bladder cancer -- and thus tailor treatment, according to a team led by Rui Sun, PhD, of the Affiliated Hospital of Qingdao University in Shandong, China. The group's findings were published January 25 in Insights into Imaging. "Lymph node metastasis affects the survival rate of bladder cancer patients … [and] because of the limitations of curren...
Source: AuntMinnie.com Headlines - January 29, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties CT Artificial Intelligence Genitourinary Radiology Source Type: news

Bladder Cancer: Is Active Surveillance the Way Forward? Bladder Cancer: Is Active Surveillance the Way Forward?
Active surveillance is safe and improves quality of life but requires careful patient selection and relevant follow-up, said one expert.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 24, 2024 Category: Internal Medicine Tags: Hematology-Oncology Source Type: news

U.S. Food and Drug Administration Grants Full Approval for Balversa to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations
Balversa® is the First and Only Targeted Therapy for Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Susceptible Fibroblast Growth Factor Receptor Alterations Phase 3 THOR Study Showed a 36 Percent Reduction in the Risk... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 19, 2024 Category: Drugs & Pharmacology Source Type: news

European Commission approves Roche ’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients,  nurses and physicians1-5Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possibleBasel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq ® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer...
Source: Roche Investor Update - January 16, 2024 Category: Pharmaceuticals Source Type: news

European Commission approves Roche ’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types
Subcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by cancer patients,  nurses and physicians1-5Tecentriq SC reduces treatment time by approximately 80%, compared with standard IV infusion6Roche is working closely with national health systems in Europe to ensure patients can access Tecentriq SC as quickly as possibleBasel, 16 January 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for Tecentriq ® SC (atezolizumab), the European Union (EU)’s first PD-(L)1 cancer...
Source: Roche Media News - January 16, 2024 Category: Pharmaceuticals Source Type: news